GAGE12G: A Protein Involved in Neural Signaling and Pain Perception

Target Name: GAGE12G

NCBI ID: G645073

GAGE12G

GAGE12G: A Protein Involved in Neural Signaling and Pain Perception

GAGE12G (AL4) is a protein that is expressed in various tissues of the body, including the brain, heart, lungs, and gastrointestinal tract. It is a member of the G-protein-coupled receptor (GPCR) family, which is a large superfamily of transmembrane proteins that play a critical role in cellular signaling. GAGE12G is characterized by its long extracellular domain, which contains a leucine-rich repeat (LRR) and a transmembrane domain.

The GPCR family is involved in a wide range of physiological processes in the body, including sensory perception, neurotransmitter signaling, and cellular signaling. GAGE12G is involved in several of these processes, including neurotransmitter signaling, pain perception, and cell signaling.

One of the key functions of GAGE12G is its role in neurotransmitter signaling. GAGE12G is a high-affinity receptor for the neurotransmitter serotonin, which is involved in a wide range of physiological processes, including mood regulation, appetite, and pain perception. GAGE12G is also involved in the regulation of neurotransmitter release and uptake, which is critical for the normal functioning of the nervous system.

In addition to its role in neurotransmitter signaling, GAGE12G is also involved in pain perception. GAGE12G is known to play a role in the regulation of pain modalities, including nociceptive pain and neuropathic pain. It is also involved in the regulation of pain modulation by neurotransmitters , such as serotonin and endocannabinoids.

Another function of GAGE12G is its role in cell signaling. GAGE12G is involved in the regulation of cellular signaling pathways that are involved in cell growth, differentiation, and survival. It is also involved in the regulation of cell adhesion and migration, which are critical for the proper functioning of tissues and organs.

GAGE12G is also involved in several other physiological processes in the body, including blood pressure, heart rate, and respiratory function. It is a critical regulator of these processes, and dysregulation of GAGE12G has been implicated in a wide range of diseases, including cardiovascular disease , neurodegenerative diseases, and respiratory disorders.

GAGE12G is also a potential drug target (or biomarker) for several diseases. For example, GAGE12G is a strong candidate for treatment of depression, anxiety, and other mood disorders. Studies have shown that GAGE12G is involved in the regulation of mood, and that dysregulation of GAGE12G has been implicated in the development of these disorders. Additionally, GAGE12G is also a potential target for pain modulation, and has been shown to be involved in the regulation of pain modulation in neuropathic pain.

GAGE12G is also a potential biomarker for several diseases, including neurodegenerative diseases. Studies have shown that GAGE12G is involved in the regulation of several key processes involved in neurodegenerative diseases, including neurotransmitter signaling, pain perception, and cellular signaling. Additionally, GAGE12G is also involved in the regulation of several key processes involved in neurodegenerative diseases, including blood pressure, heart rate, and respiratory function.

In conclusion, GAGE12G (AL4) is a protein that is involved in a wide range of physiological processes in the body. It is a member of the GPCR family and is characterized by its long extracellular domain, which contains a leucine-rich repeat (LRR ) and a transmembrane domain. GAGE12G is involved in

Protein Name: G Antigen 12G

The "GAGE12G Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GAGE12G comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets